Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.

CONCLUSION: These results indicate that FS (p-tau231 and MMSE) has a strong potential to provide an early distinction between AD and VaD.
PMID: 29453935 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - February 17, 2018 Category: Neuroscience Authors: Kiđemet-Piskač S, Babić Leko M, Blažeković A, Langer Horvat L, Klepac N, Sonicki Z, Kolenc D, Hof PR, Boban M, Mimica N, Borovečki F, Šimić G Tags: CNS Neurosci Ther Source Type: research